(Q36680989)

English

Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan

scientific article published on January 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

tacrolimus ointment

1 reference

based on heuristic

inferred from title

atopic dermatitis

1 reference

based on heuristic

inferred from title

author name string

Hidemi Nakagawa

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

235-246

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200626050-00001

21 January 2018

Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do oral antihistamines stop the itch of atopic dermatitis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid-induced dermal atrophy. Investigations on discontinuous application

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glaucoma and amaurosis associated with long-term application of topical corticosteroids to the eyelids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacophysiology of atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading of the severity of atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenocortical function in patients with severe atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cushing's syndrome after topical application of corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory effect of FK-506 on human skin mast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of daily applications between topical corticosteroid and tacrolimus ointments on normal skin: evaluation with noninvasive methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights into atopic dermatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17163257

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200626050-00001

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36680989&oldid=1646210992"